Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
Clinical trial NCT03210532 · COMPLETED
Trial details
- NCT number
- NCT03210532
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-07
- Primary completion
- 2017-09-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.